Bendamustine With or Without Cyclophosphamide in Preventing GVHD in Patients Undergoing Stem Cell Transplant
Clinical trial NCT04022239 · RECRUITING
Trial details
- NCT number
- NCT04022239
- Sponsor
- M.D. Anderson Cancer Center
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-03-13
- Primary completion
- 2027-07-31
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.